NGF-induced TrkA/CD44 association is involved in tumor aggressiveness and resistance to lestaurtinib - Aix-Marseille Université Accéder directement au contenu
Article Dans Une Revue Oncotarget Année : 2015

NGF-induced TrkA/CD44 association is involved in tumor aggressiveness and resistance to lestaurtinib

Résumé

There is accumulating evidence that TrkA and its ligand Nerve Growth Factor (NGF) are involved in cancer development. Staurosporine derivatives such as K252a and lestaurtinib have been developed to block TrkA kinase signaling, but no clinical trial has fully demonstrated their therapeutic efficacy. Therapeutic failures are likely due to the existence of intrinsic signaling pathways in cancer cells that impede or bypass the effects of TrkA tyrosine kinase inhibitors. To verify this hypothesis, we combined different approaches including mass spectrometry proteomics, co-immunoprecipitation and proximity ligation assays. We found that NGF treatment induced CD44 binding to TrkA at the plasma membrane and subsequent activation of the p115RhoGEF/RhoA/ROCK1 pathway to stimulate breast cancer cell invasion. The NGF-induced CD44 signaling was independent of TrkA kinase activity. Moreover, both TrkA tyrosine kinase inhibition with lestaurtinib and CD44 silencing with siRNA inhibited cell growth in vitro as well as tumor development in mouse xenograft model; combined treatment significantly enhanced the antineoplastic effects of either treatment alone. Altogether, our results demonstrate that NGF-induced tyrosine kinase independent TrkA signaling through CD44 was sufficient to maintain tumor aggressiveness. Our findings provide an alternative mechanism of cancer resistance to lestaurtinib and indicate that dual inhibition of CD44 and TrkA tyrosine kinase activity may represent a novel therapeutic strategy.

Domaines

Cancer
Fichier principal
Vignette du fichier
3227-50945-2-PB.pdf (3.82 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03623750 , version 1 (02-01-2024)

Licence

Paternité

Identifiants

Citer

Léo Aubert, Matthieu Guilbert, Cyril Corbet, Elisabeth Génot, Eric Adriaenssens, et al.. NGF-induced TrkA/CD44 association is involved in tumor aggressiveness and resistance to lestaurtinib. Oncotarget, 2015, 6 (12), pp.9807-9819. ⟨10.18632/oncotarget.3227⟩. ⟨hal-03623750⟩
28 Consultations
3 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More